| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C10H14N2O |
| Molar mass | 178.235 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Epiboxidine is a chemical compound which acts as apartial agonist at neuralnicotinic acetylcholine receptors, binding to both theα3β4 and theα4β2subtypes. It was developed as a less toxicanalogue of the potent frog-derivedalkaloidepibatidine, which is around 200 times stronger thanmorphine as ananalgesic but is deadly toxic.
Epiboxidine is around one-tenth as potent as epibatidine as an α4β2 agonist, but has around the same potency as an α3β4 agonist. It has only one-tenth of the analgesic power of epibatidine, but is also much less toxic.[1][2][3]
Despite reduced toxicity compared to epibatidine, epiboxidine itself is still too toxic to be developed as a drug for use in humans. It is used in scientific research[4] and as a parent compound to derive newer analogues which may be safer and have greater potential for clinical development.[5][6][7]